Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation - safety, efficacy, and patient adherence
about
Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis.Novel Therapeutic Options for the Treatment of Mineral Metabolism Abnormalities in End Stage Renal Disease.Lanthanum carbonate oral powder: satisfaction, preference and adherence in French and Spanish patients with end-stage renal disease.
P2860
Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation - safety, efficacy, and patient adherence
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Lanthanum carbonate for the co ...... fficacy, and patient adherence
@ast
Lanthanum carbonate for the co ...... fficacy, and patient adherence
@en
Lanthanum carbonate for the co ...... fficacy, and patient adherence
@nl
type
label
Lanthanum carbonate for the co ...... fficacy, and patient adherence
@ast
Lanthanum carbonate for the co ...... fficacy, and patient adherence
@en
Lanthanum carbonate for the co ...... fficacy, and patient adherence
@nl
prefLabel
Lanthanum carbonate for the co ...... fficacy, and patient adherence
@ast
Lanthanum carbonate for the co ...... fficacy, and patient adherence
@en
Lanthanum carbonate for the co ...... fficacy, and patient adherence
@nl
P2093
P2860
P3181
P356
P1476
Lanthanum carbonate for the co ...... fficacy, and patient adherence
@en
P2093
César Ruiz-García
Iara Dasilva
Jordi Bover
José Ballarín
M Jesús Lloret
Yaima Barreiro
P2860
P304
P3181
P356
10.2147/PPA.S31694
P407
P577
2013-11-06T00:00:00Z